Guidelines for thalidomide use vital in Wales

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.304, 2001-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guidelines for thalidomide use vital

Inpharma, Vol. 1, Iss. 1280, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The Use of Thalidomide in Myeloma Therapy as an Effective Anticancer Drug

Current Cancer Drug Targets, Vol. 6, Iss. 4, 2006-06 ,pp. : 325-331

Bentham Science Publishers

Access to resources Recommend Favorite

NICE Methodological Guidelines and Decision Making in the National Health Service in England and Wales

By Gafni A. Birch S.

PharmacoEconomics, Vol. 21, Iss. 3, 2003-01 ,pp. : 149-157

Adis International

Access to resources Recommend Favorite

Vigabatrin: guidelines for paediatric use revised

Inpharma, Vol. 1, Iss. 1239, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Guidelines on topical corticosteroid use in pregnancy

Reactions Weekly, Vol. 1, Iss. 1363, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite